Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [338]
News [1559]
Articles [69]
Editorials [3]
Conferences [72]
elearning [15]
Editor's ASCO 2016 Roundup
Prof Gordon McVie - ecancer Editor in Chief
Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )
16 Jun 2016
Chemotherapy combination with capecitabine extends survival after pancreatic...
Prof John Neoptolemos - University of Liverpool, Liverpool, UK
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )
5 Jun 2016
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma
Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
5 Jun 2016
Advanced hepatocellular carcinoma and personalised therapy
Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Advanced hepatocellular carcinoma and personalised therapy ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2016
Latest in hepatocellular carcinoma treatments
Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Latest in hepatocellular carcinoma treatments ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2016
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine...
Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )
3 Jun 2016
Direct activation of STING in the tumour microenvironment leads to potent and...
Dr Thomas Dubensky - Aduro Biotech, Berkley, USA
Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )
4 May 2016
Understanding personalised medicine - the e-learning course
Prof Gordon McVie
Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )
4 May 2016
p62: Metabolism and the tumour microenvironment
Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La...
p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )
29 Apr 2016
Editor's Choice for April 2016
Prof Gordon McVie - ecancer Editor
Editor's Choice for April 2016 ( Prof Gordon McVie - ecancer Editor )
29 Apr 2016
Targeting AFP in hepatocellular cancer
Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA
Targeting AFP in hepatocellular cancer ( Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA )
5 Apr 2016
Patient perspective on immunotherapy and the ITOC-3 conference
Peter Trayhurn - Patient advocate
Patient perspective on immunotherapy and the ITOC-3 conference ( Peter Trayhurn - Patient advocate )
4 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation